Real-time enrollment status for this advanced hr+/her2- breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:48 PM UTC
| NCT Number | NCT07604571 |
| Recruiting Status | Recruiting |
| Condition | Advanced HR+/HER2- Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 194 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 30, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT07604571 is currently recruiting participants. This clinical trial study for advanced hr+/her2- breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07604571 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07604571 was last updated 1 week ago (June 30, 2026). HelloStudys verifies this status automatically.